LEADER 01669nam  2200541   450 
001 9910789327303321
005 20230803033951.0
010   $a1-909453-72-2
010   $a1-909453-73-0
035   $a(CKB)3430000000000055
035   $a(SSID)ssj0001599969
035   $a(PQKBManifestationID)16306843
035   $a(PQKBTitleCode)TC0001599969
035   $a(PQKBWorkID)14892631
035   $a(PQKB)10683670
035   $a(MiAaPQ)EBC5092526
035   $a(Au-PeEL)EBL5092526
035   $a(CaPaEBR)ebr11451413
035   $a(OCoLC)863862657
035   $a(EXLCZ)993430000000000055
100   $a20171107h20132013  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aBioanalysis of biotherapeutics /$feditor, Boris Gorovits
210  1$aLondon, England :$cFuture Science Ltd,$d2013.
210  4$dİ2013
215   $a1 online resource (92 pages) $cillustrations (some color), graphs, tables
225 1 $aFuture Science,$x2047-332X
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-909453-74-9 
320   $aIncludes bibliographical references at the end of each chapters and index.
410  0$aFuture science.
606   $aBiological products$xTherapeutic use
606   $aBiomolecules$xAnalysis
615  0$aBiological products$xTherapeutic use.
615  0$aBiomolecules$xAnalysis.
676   $a615.7
702   $aGorovits$b Boris
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910789327303321
996   $aBioanalysis of biotherapeutics$93752246
997   $aUNINA